SECRETARY
OF THE BOARD
Dr.
Peter M. Small
Senior Program Officer
BMGF
|
 |
Peter M. Small is a Senior Program Officer for Tuberculosis at the Bill and Melinda Gates Foundation. In this capacity, for the past 5 years he has been responsible for developing and implementing the foundation’s tuberculosis activities.
Dr. Small received his undergraduate degree from Princeton University (1981) and his medical degree from the University of Florida (1985). He completed his post graduate training in internal medicine at UCSF (where he served as Chief Medical Resident) and infectious diseases at Stanford University. Immediately prior to joining the Gates Foundation in September of 2002, he was on the faculty of Stanford’s Division of Infectious Disease and Geographic Medicine where he was actively involved in research, teaching and patient care.
Dr. Small is a global expert in several aspects of TB epidemiology, biology and control. He has published more than 100 articles in peer reviewed journals including landmark studies in the New England Journal of Medicine, Lancet, Science, and Nature that helped to shape the public health response to the resurgence of tuberculosis in the 1990’s. Much of this involved collaborative efforts with basic scientists, public health officials and clinicians to use of molecular epidemiologic techniques to address pragmatic questions about the control of tuberculosis. This work included population based field research projects in Latin America, Africa, Asia and Europe. In 2002, he was awarded the Princess Chichibu Global Tuberculosis Award for his pioneering contributions to global tuberculosis control. In addition to his work at the Gates Foundation, he is currently a Professor at the Institute of Systems Biology in Seattle where his lab is focused on the nature and consequences of genetic variability within the species M. tuberculosis as it pertains to fundamental questions about mycobacterial ecology and evolution.
He served as a member of the Institute of Medicine’s committee addressing the elimination of tuberculosis in the United States and currently serves as a member of the WHO Stop TB Coordinating Board. Dr. Small is also on the Board of the Global Alliance for TB Drug Development and the Aeras Global TB Vaccine Foundation.
|